ARTICLE | Clinical News
Protelos strontium ranelate regulatory update
October 4, 2004 7:00 AM UTC
EMEA granted marketing authorization for Protelos, an agent that increases bone formation and decreases bone resorption, to treat postmenopausal osteoporosis. ...